| 01.07.2022 08:02:31 | |
|---|---|
| Cena | |
| 168,30 EUR | |
| Změna | -0,18% (-0,30) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Munich |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 450.895 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - |
| Prodej (částka) | - |
| Otevírací cena | 168,30 EUR |
| Max | 168,30 EUR |
| Min | 168,30 EUR |
| Závěrečná cena (předchozí den) | 168,60 EUR |
| Cena vážená obchodovaným objemem | 169,12 EUR |
| Objem (kusy) | 0 |
| Obchodovaný objem | 0,00 |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | 0 |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 29.06.2022 |
|
Global Equity Ratings |
|
| 25.05.2022 |
|
Global Equity Ratings |
|
| 04.05.2022 |
|
Global Equity Ratings |
|
| 27.04.2022 |
|
Global Equity Ratings |
|
| 14.04.2022 |
|
Global Equity Ratings |
|
Všechny burzy pro JOHNSON & JOHNSON
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 01.07.2022 | 17:35 | 170,84 EUR | 0,81 | 238 |
| Vienna Stock Exchange | 01.07.2022 | 17:32 | 170,68 EUR | 0,00 | 3 |
| Tradegate | 01.07.2022 | 22:26 | 172,14 EUR | 1,31 | 149 |
| Stuttgart | 01.07.2022 | 21:37 | 172,00 EUR | 0,01 | 12 |
| SIX Swiss Exchange | 30.06.2022 | 17:36 | 168,00 CHF | 0,00 | 1 |
| SIX Swiss Exchange | 30.03.2020 | 17:35 | 150,00 USD | 0,00 | 1 |
| NYSE | 01.07.2022 | 22:00 | 179,52 USD | 981,17 | 64.153 |
| Munich | 01.07.2022 | 08:02 | 168,30 EUR | 0,00 | 1 |
| London Stock Exchange | 01.07.2022 | 17:35 | 177,31 USD | 0,04 | 10 |
| Hanover | 01.07.2022 | 08:02 | 167,80 EUR | 0,00 | 1 |
| Hamburg | 01.07.2022 | 08:13 | 168,50 EUR | 0,00 | 2 |
| Frankfurt | 01.07.2022 | 17:13 | 171,12 EUR | 0,04 | 7 |
| Duesseldorf | 01.07.2022 | 14:01 | 169,68 EUR | 0,00 | 9 |
| Berlin | 01.07.2022 | 08:08 | 167,72 EUR | 0,00 | 1 |
| 01.07.2022 08:02:31 | |
|---|---|
| Cena | |
| 168,30 EUR | |
| Změna | -0,18% (-0,30) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Munich |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 450.895 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - |
| Prodej (částka) | - |
| Otevírací cena | 168,30 EUR |
| Max | 168,30 EUR |
| Min | 168,30 EUR |
| Závěrečná cena (předchozí den) | 168,60 EUR |
| Cena vážená obchodovaným objemem | 169,12 EUR |
| Objem (kusy) | 0 |
| Obchodovaný objem | 0,00 |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | 0 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | +10,94% | +20,21% | +36,61% |
| Výkonn. (abs.) | +16,60 | +28,30 | +45,10 |
| Beta | 0,31 | 0,31 | 0,57 |
| Volatilita | 20,06 | 17,78 | 21,56 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 169,51 EUR (22) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 166,21 EUR (19) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 162,02 EUR (30) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 151,85 EUR (76) |
| YTD Max| datum | 175,02 EUR (28.04.2022) |
| YTD Min | datum | 139,20 EUR (24.02.2022) |
| 52týdenní max. | datum | 175,02 EUR (28.04.2022) |
| 52týdenní min. | datum | 135,90 EUR (04.10.2021) |
Logo společnosti
Kontakty
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon:1-732-524-0400 |
| Fax:- |
| E-mail:- |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON | |
Profil společnosti
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Členové představenstva
| Alex Gorsky | Chairman of Board of Directors |
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Darius Adamczyk | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Ian Davis | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Joaquin Duato | Chairman of Managing Board |
| Mathai Mammen | Member of Executive Committee |
| Peter M. Fasolo | Member of Executive Committee |
| William N. Hait | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| James Swanson | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |
| Vanessa Broadhurst | Member of Executive Committee |